Revised SPC: Tybost (cobicistat) tablets

SPC now highlights co-administration with clopidogrel is not recommended as cobicistat is expected to decrease clopidogrel active metabolite levels. No effect on prasugrel pharmacokinetics is expected however, and if Tybost is given concurrently no dose adjusted is required.

Source:

electronic Medicines compendium